Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancreatic kininogenase plus tadalafil for diabetes-associated erectile dysfunction
ChiCTR2100047068Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Feb 2021
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of pancreatic kininogenase in erectile dysfunction (ED) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoints: Efficacy and Safety. Started Feb 2021; status: recruiting.
02
Drugs
pancreatic kininogenase
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on ChiCTR2100047068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047068.